Specific plasmin inactivation by anticatalytic antibody
US11066482B2 · kind B2 · utility
0Cited by
0References
19Claims
0Family size
Inventor
Key dates
| Filing date | Sep 21, 2018 |
| Grant date | Jul 20, 2021 |
| Priority date | — |
| Expiry date | Apr 18, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods and pharmaceutical compositions for treating hemorrhage or bleeding are provided. The pharmaceutical compositions include an effective amount of an antifibrinolytic composition that reduces or inhibits hemorrhage or bleeding in a subject.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.